ISPOR - Understanding the average svr rates of hepatitis c treatments and their implications on clinical and economic outcomes- then vs. Now

Full Text

Understanding the average svr rates of hepatitis c treatments and their implications on clinical and economic outcomes- then vs. Now

Abstract

Authors

C. Liberatore E. Hawryluk K. Lee E. O’Connell E. Faulkner

Back to Volume 18, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now